Çocuklarda Romatolojik Hastalıklarda Baş Ağrısı

Leonardi M, Grazzi L, D'Amico D, et al. Global Burden of Headache Disorders in Children and Adolescents 2007-2017. Int J Environ Res Public Health. 2020;18(1):250. Published 2020 Dec 31. doi:10.3390/ijerph18010250

Oni L, Sampath S. Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps. Front Pediatr. 2019;7:257. Published 2019 Jun 27. doi:10.3389/fped.2019.00257

Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798-806. doi:10.1136/ard.2009.116657

Pacheva IH, Ivanov IS, Stefanova K, et al. Central Nervous System Involvement in Henoch-Schonlein Purpura in Children and Adolescents. Case Rep Pediatr. 2017;2017:5483543. doi:10.1155/2017/5483543

Garzoni L, Vanoni F, Rizzi M, et al. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology (Oxford). 2009;48(12):1524-1529. doi:10.1093/rheumatology/kep282

Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197-1202. doi:10.1016/S0140-6736(02)11279-7

Jone PN, Tremoulet A, Choueiter N, et al. Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association [published correction appears in Circulation. 2025 Feb 25;151(8):e677-e679. doi: 10.1161/CIR.0000000000001313.] [published correction appears in Circulation. 2025 Apr;151(13):e863. doi: 10.1161/CIR.0000000000001324.]. Circulation. 2024;150(23):e481-e500. doi:10.1161/CIR.0000000000001295

Liu X, Zhou K, Hua Y, et al. Neurological involvement in Kawasaki disease: a retrospective study. Pediatr Rheumatol Online J. 2020;18(1):61. Published 2020 Jul 14. doi:10.1186/s12969-020-00452-7

Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC. Diagnosis and classification of polyarte ritis nodosa. J Autoimmun 2014;48-49:84-9.

Ozen S, Anton J, Arisoy N, Bakkaoglu A, Besbas N, Brogan P, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 1992;120:206-9.

Demir S, Sonmez HE, Ozen S. Vasculitis: Decade in Review. Curr Rheumatol Rev. 2019;15(1):14-22.

Eleftheriou D, Dillon MJ, Tullus K, et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum. 2013;65(9):2476-85.

de Boysson H, L. Polyarteritis No dosa Neurologic Manifestations. Neurol Clin. 2019;37(2):345-357..

Guirola R, Hunter JV, Perez M, Muscal E. Childhood polyarteritis nodosa presenting with central nervous system manifestations and the posterior reversible encephalopathy syndrome. J Child Neurol. 2014;29(1):103-7.

Kasap Cuceoglu M, Sener S, Batu ED, et al. Sys tematic review of childhood-onset polyarteritis nodosa and DADA2. Semin Arthritis Rheum. 2021;51(3):559-64

Clemente G, Hilário MO, Len C, et al. Brazilian multicenter study of 71 patients with juvenile-onset Takayasu's arteritis: clinical and angiographic features. Rev Bras Reumatol Engl Ed. 2016;56(2):145-151. doi:10.1016/j.rbre.2016.01.004

Aeschlimann FA, Barra L, Alsolaimani R, et al. Pre sentation and Disease Course of Childhood-Onset Versus Adult-Onset Takayasu Arteritis. Arthritis Rheumatol. 2019;71(2):315-23.

Bolek EC, Kaya Akca U, Sari A, et al. Is Takayasu's arteritis more severe in children?. Clin Exp Rheumatol. 2021;39 Suppl 129(2):32-38. doi:10.55563/clinexprheumatol/kr357t

Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004;117(1):39-50. doi:10.1016/j.amjmed.2004.02.030

Rossi CM, Di Comite G. The clinical spectrum of the neurological involvement in vasculitides. J Neurol Sci. 2009;285(1-2):13-21. doi:10.1016/j.jns.2009.05.017

Chhetri MK, Bhattacharya AK, Kumar T. Headache in rheumatological disorders. J Indian Med Assoc. 2011;109(646):648–9.

Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA. Paediatric Behçet's disease: a UK tertiary centre experience. Clin Rheumatol. 2016;35(10):2509-2516. doi:10.1007/s10067-016-3187-z

Gallizzi R, Pidone C, Cantarini L, et al. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry [published correction appears in Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29. doi: 10.1186/s12969-018-0241-1.]. Pediatr Rheumatol Online J. 2017;15(1):84. Published 2017 Dec 21. doi:10.1186/s12969-017-0213-x

Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958-964. doi:10.1136/annrheumdis-2015-208491

Uluduz D, Kürtüncü M, Yapıcı Z, et al. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology. 2011;77(21):1900-1905. doi:10.1212/WNL.0b013e318238edeb

Saadoun D, Wechsler B, Resche-Rigon M, et al. Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum. 2009;61(4):518-526. doi:10.1002/art.24393

Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A. Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis. 2013;8:18. Published 2013 Jan 29. doi:10.1186/1750-1172-8-18

Benseler SM, deVeber G, Hawkins C, et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum. 2005;52(7):2159-2167. doi:10.1002/art.21144

Moharir M, Shroff M, Benseler SM. Childhood central nervous system vasculitis. Neuroimaging Clin N Am. 2013;23(2):293-308. doi:10.1016/j.nic.2012.12.008

Schwartz N, Mitnick HJ, Nowatzky J. Headaches related to rheumatologic disease. Curr Pain Headache Rep. 2013;17(12):381. doi:10.1007/s11916-013-0381-4

Siamopoulou-Mavridou A, Mavridis AK, Dimou G, Drosos AA. Clinical and serological spectrum of systemic lupus erythematosus in Greek children. Clin Rheumatol. 1991;10(3):264-268. doi:10.1007/BF02208687

Hanly JG, Urowitz MB, O'Keeffe AG, et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study [published correction appears in Arthritis Rheum. 2014 Jun;66(6):1671]. Arthritis Rheum. 2013;65(11):2887-2897. doi:10.1002/art.38106

Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008;67(2):195-205. doi:10.1136/ard.2007.070367

Kim JM, Kwok SK, Ju JH, Kim HY, Park SH. Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus: a 15-year experience. Lupus. 2012;21(5):542-547. doi:10.1177/0961203311435267

Dave S, Longmuir R, Shah VA, Wall M, Lee AG. Intracranial hypertension in systemic lupus erythematosus. Semin Ophthalmol. 2008;23(2):127-133. doi:10.1080/08820530801888188

Kısaarslan AP, Çiçek SÖ, Batu ED, et al. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study. Joint Bone Spine. 2023;90(4):105559. doi:10.1016/j.jbspin.2023.105559

Nagaraju K, Casciola-Rosen L, Lundberg I, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 2005;52(6):1824-1835. doi:10.1002/art.21103

Tsai YY, Yang YH, Yu HH, Wang LC, Lee JH, Chiang BL. Fifteen-year experience of pediatric-onset mixed connective tissue disease. Clin Rheumatol. 2010;29(1):53-58. doi:10.1007/s10067-009-1276-y

Bennett RM, Bong DM, Spargo BH. Neuropsychiatric problems in mixed connective tissue disease. Am J Med. 1978;65(6):955-962. doi:10.1016/0002-9343(78)90747-7

Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539-551. doi:10.1056/NEJMra1104650

Wallace ZS, Perugino C, Matza M, Deshpande V, Sharma A, Stone JH. Immunoglobulin G4-related Disease. Clin Chest Med. 2019;40(3):583-597. doi:10.1016/j.ccm.2019.05.005

Kaya Akca U, Kose H, Kurt T, et al. A rare disease with many faces: a multicentre registry of IgG4-related disease in children. Rheumatology (Oxford). 2025;64(4):2185-2192. doi:10.1093/rheumatology/keae497

Holzinger D, Kessel C, Omenetti A, Gattorno M. From bench to bedside and back again: translational research in autoinflammation. Nat Rev Rheumatol. 2015;11(10):573-585. doi:10.1038/nrrheum.2015.79

de Jesus AA, Goldbach-Mansky R. Genetically defined autoinflammatory diseases. Oral Dis. 2016;22(7):591-604. doi:10.1111/odi.12448

Uccelli A, Gattorno M. Neurological manifestations in autoinflammatory diseases. Clin Exp Rheumatol. 2018;36 Suppl 110(1):61-67.

Ben-Chetrit E, Gattorno M, Gul A, et al. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Ann Rheum Dis. 2018;77(11):1558-1565. doi:10.1136/annrheumdis-2017-212515

Tanaka N, Izawa K, Saito MK, et al. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Arthritis Rheum. 2011;63(11):3625-3632. doi:10.1002/art.30512

Cuisset L, Jeru I, Dumont B, et al. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France [published correction appears in Ann Rheum Dis. 2012 Jul;71(7):1264. Lemelle, C [corrected to Lemelle, I]]. Ann Rheum Dis. 2011;70(3):495-499. doi:10.1136/ard.2010.138420

Levy R, Gérard L, Kuemmerle-Deschner J, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. 2015;74(11):2043-2049. doi:10.1136/annrheumdis-2013-204991

Montealegre Sanchez GA, Hashkes PJ. Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes. Dev Med Child Neurol. 2009;51(6):420-428. doi:10.1111/j.1469-8749.2009.03336.x

Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301-305. doi:10.1038/ng756

Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004;50(2):607-612. doi:10.1002/art.20033

Prieur AM. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol. 2001;19(1):103-106.

Keddie S, Parker T, Lachmann HJ, Ginsberg L. Cryopyrin-Associated Periodic Fever Syndrome and the Nervous System. Curr Treat Options Neurol. 2018;20(10):43. Published 2018 Sep 3. doi:10.1007/s11940-018-0526-1

Özen S. Update on the epidemiology and disease outcome of Familial Mediterranean fever. Best Pract Res Clin Rheumatol. 2018;32(2):254-260. doi:10.1016/j.berh.2018.09.003

Milhavet F, Cuisset L, Hoffman HM, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29(6):803-808. doi:10.1002/humu.20720

Canpolat M, Gumus H, Gunduz Z, et al. Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey [published correction appears in Neuropediatrics. 2017 Oct;48(5):402. doi: 10.1055/s-0037-1599783.]. Neuropediatrics. 2017;48(2):79-85. doi:10.1055/s-0036-1593374

Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever. Pediatr Neurol. 1993;9(4):301-302. doi:10.1016/0887-8994(93)90068-n

Feld O, Yahalom G, Livneh A. Neurologic and ot her systemic manifestations in FMF: Published and own experience. Best Pract Res Clin Rheumatol. 2012.26(1):119–33.

Frenkel J, Simon A. Mevalonate Kinase Deficiency. In: Hashkes PJ, Laxer RM, Simon A, editors. Text book of Autoinflammation. 1st ed. Cham: Springer; 2019. p. 315–27.

Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016;17(8):914-921. doi:10.1038/ni.3457

Cuisset L, Drenth JP, Simon A, et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet. 2001;9(4):260-266. doi:10.1038/sj.ejhg.5200614

Elhani I, Hentgen V, Grateau G, Georgin-Lavialle S. Neurological manifestations in mevalonate kinase deficiency: A systematic review. Mol Genet Metab. 2022;136(2):85-93. doi:10.1016/j.ymgme.2022.04.006

Cantarini L, Lucherini OM, Muscari I, et al. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev. 2012;12(1):38-43. doi:10.1016/j.autrev.2012.07.020

Lachmann HJ, Papa R, Gerhold K, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis. 2014;73(12):2160-2167. doi:10.1136/annrheumdis-2013-204184